Condition

SARS-CoV 2 (2)

COVID-19 (1)

Overall Status

Active, not recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Johns Hopkins University (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Collaborator

Bloomberg Foundation (1)

National Center for Advancing Translational Science (NCATS) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

State of Maryland (1)

United States Department of Defense (1)

Intervention

bicalutamide 150 mg oral tablet (1)

plasma from a volunteer donor (1)

sars-cov-2 convalescent plasma (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

SARS-CoV 2

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

SARS-CoV 2 Trial in United States (SARS-CoV-2 convalescent plasma, Plasma from a volunteer donor)

Active, not recruiting

SARS-CoV 2

SARS-CoV-2 convalescent plasma
Plasma from a volunteer donor

Birmingham, Alabama
+24 more

Jun 2, 2022

COVID-19, SARS-CoV 2 Trial in Baltimore (Bicalutamide 150 Mg Oral Tablet)

Withdrawn

COVID-19
SARS-CoV 2

Bicalutamide 150 Mg Oral Tablet

Baltimore, Maryland

Johns Hopkins Hospital

Mar 2, 2021